We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-3.17%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.7B
AUM Growth
-$119M
Cap. Flow
-$1.99M
Cap. Flow %
-0.12%
Top 10 Hldgs %
26.27%
Holding
258
New
9
Increased
68
Reduced
165
Closed
10

Top Buys

Rank Stock Value
1
FOUR icon
Shift4
FOUR
+$11.6M
2
LKQ icon
LKQ Corp
LKQ
+$10.4M
3
DOX icon
Amdocs
DOX
+$9.78M
4
GTLS
Chart Industries
GTLS
+$8.47M
5
FOLD
Amicus Therapeutics
FOLD
+$5.91M

Top Sells

Rank Stock Value
1
LRN icon
Stride
LRN
+$25.9M
2
TKO icon
TKO Group
TKO
+$9.39M
3
VRNA
Verona Pharma
VRNA
+$7.87M
4
HLIT icon
Harmonic Inc
HLIT
+$3.61M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$3.11M

Sector Composition

Rank Sector Weight
1 Healthcare 32.28%
2 Technology 27.73%
3 Industrials 15.2%
4 Consumer Discretionary 7.22%
5 Communication Services 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLIT icon
251
Harmonic Inc
HLIT
$1.26B
– –
-272,702
Closed -$3.61M
IWC icon
252
iShares Micro-Cap ETF
IWC
$1.49B
– –
-7,645
Closed -$997K
QRHC icon
253
Quest Resource Holding
QRHC
$31.2M
– –
-272,264
Closed -$1.77M
STAA icon
254
STAAR Surgical
STAA
$1.25B
– –
-47,365
Closed -$1.15M
ZYXI
255
DELISTED
Zynex
ZYXI
– –
-228,786
Closed -$1.83M
ZUO
256
DELISTED
Zuora, Inc.
ZUO
– –
-288,834
Closed -$2.87M
RVNC
257
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-678,541
Closed -$2.06M
CDMO
258
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-246,494
Closed -$3.04M
7 8 9 10
11

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Rice Hall James & Associates held 258 positions worth $1.7B, down 6.5% from $1.82B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q1 2025 filing shows 9 new, 68 increased, 165 reduced and 10 closed positions. Its largest new stake was Chart Industries: 45,975 shares worth $6.64M. The largest sale was Stride, an estimated $25.9M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q1 2025 buy was Chart Industries: 45,975 shares worth $6.64M.
  • Rice Hall James & Associates added most to Shift4 in Q1 2025, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q1 2025 reduction was Stride, cutting an estimated $25.9M.
  • Rice Hall James & Associates fully exited Harmonic Inc in Q1 2025, selling an estimated $3.61M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $1.7B portfolio in Q1 2025.
  • Rice Hall James & Associates opened 9 new positions and closed 10 in Q1 2025.
  • Rice Hall James & Associates's portfolio value fell 6.5% quarter-over-quarter to $1.7B.

Based on Rice Hall James & Associates's 13F filing for Q1 2025, filed 1 May 2025.